Target intelligence / Profile preview

Tubulin (colchicine binding site) (CBS) (CBS)

Target
CBS
Molecular classification
Cytoskeletal protein, GTP-binding protein, Heterodimeric protein
01

Overview

Tubulin is a heterodimeric protein composed of alpha and beta subunits that serves as the fundamental building block of microtubules, which are essential for maintaining cell structure, facilitating intracellular transport, and forming the mitotic spindle during cell division (UniProt P07437). The colchicine binding site (CBS) is a well-defined hydrophobic pocket located at the interface between the alpha and beta-tubulin subunits within a single heterodimer (PubMed 22101561). Binding of small molecules to this site prevents the tubulin heterodimer from transitioning from a curved to a straight conformation, a step required for its successful incorporation into the growing microtubule polymer (PubMed 24512319). Consequently, CBS inhibitors act as microtubule-destabilizing agents, leading to the disruption of the mitotic spindle, cell cycle arrest in the G2/M phase, and the induction of apoptosis (PubMed 22101561). While colchicine is a long-standing treatment for inflammatory conditions such as gout and Familial Mediterranean Fever (StatPearls), newer CBS-targeting agents are being developed as potent anti-cancer therapies and vascular disrupting agents (VDAs) that selectively target the disorganized blood vessels of solid tumors (PubMed 24512319).

Other names
Colchicine binding siteCBSTubulin-colchicine domainColchicine siteColchicine binding pocket
02

Mechanism of action

Inhibition of microtubule polymerization by binding to the alpha/beta-tubulin interface, preventing the curved-to-straight conformational transition required for microtubule assembly.

03

Biological functions

Microtubule polymerizationMitotic spindle formationCell divisionIntracellular transportCell motility
04

Disease associations

CancerGoutFamilial Mediterranean FeverPericarditisBehçet's disease
05

Safety considerations

Peripheral neuropathyGastrointestinal toxicityMyelosuppressionNarrow therapeutic indexP-glycoprotein mediated drug resistance
06

Interacting drugs

Colchicine

6 more in the full profile.

07

Biomarkers

Beta-III tubulin (TUBB3) expressionMitotic indexStathmin-1 levels

Beyond the preview

Go deeper on Tubulin (colchicine binding site) (CBS) (CBS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin (colchicine binding site) (CBS) (CBS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call